AMEA
The first, FDA-approved, liquid CGP test
with guideline-recommended biomarkers.1-4
Fastest turnaround time
with results in 5 days1-4*†
For the complete intended use statement including companion diagnostic indications,
please see the Guardant360 CDx Technical Information: Guardant360CDx.com/technicalinfo
Low reportable range
down to 0.001% MAF5
CGP, comprehensive genomic profiling; MAF, mutant allele fraction.
*Of FDA-approved comprehensive liquid biopsies as of February 2024.
†Fastest median turnaround time from sample receipt to results based on stated median turnaround times from Integra Connect data